SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 51 of 100
Health
4 Reasons Why Sanofi Is Buying Bioverativ for $11.6 Billion
By
Hallie Detrick
January 22, 2018
Health
These Hospitals Are Sick of High Drug Prices. So They’re Starting Their Own Nonprofit Drug Company
By
Sy Mukherjee
January 18, 2018
Health
How Genetically Modified Cows Could Help Us Beat One of the World’s Deadliest Viruses
By
Sy Mukherjee
January 10, 2018
Health
Bill Gates Just Delivered a Powerful Message to the Drug Industry
By
Sy Mukherjee
January 9, 2018
Health
Pfizer Is Ending Research Into New Drugs for Alzheimer’s and Parkinson’s Diseases
By
Reuters
January 8, 2018
Health
Say Goodbye to Clinical Trials That Don’t Teach
By
Clifton Leaf
January 6, 2018
Health
This Obesity Fighting Drug Could Melt Fat and Lower Cholesterol—Without Suppressing Your Appetite
By
Sy Mukherjee
January 5, 2018
Health
A Diabetes Drug Could Help Alzheimer’s Patients Reverse Memory Loss
By
Emily Price
January 2, 2018
Health
2017 Saw the Most New Drugs Approved in Over 20 Years
By
Reuters
January 2, 2018
Health
Martin Shkreli’s Lawyer Will Probably Join Him in Prison
By
David Z. Morris
December 27, 2017
Finance
Roche to Buy U.S. Cancer Drugmaker Ignyta for $1.7 Billion
By
Bloomberg
December 22, 2017
Health
Life Expectancy in the U.S. Is Down for the Second Year as Opioid Deaths Soar
By
Natasha Bach
December 21, 2017
Health
Why the FDA Is About to Crack Down on Homeopathic Drugs
By
Sy Mukherjee
December 18, 2017
Health
Billionaire Drugmaker and Wife Found Dead Under ‘Suspicious’ Circumstances, Police Say
By
David Z. Morris
December 16, 2017
Leadership
Teva’s New CEO Is Cutting 25% of Jobs to Rescue the Ailing Drugmaker
By
Bloomberg
December 14, 2017
Most Popular
Banking
Markets expected the rate cut, but the ‘real surprise’ is the Fed’s opinion on the current state of the economy, quant...
By
Amanda Gerut
Law
Publishers Clearing House, company that promised 'forever' payments to sweepstakes winners, says actually nevermind
By
The Associated Press
Economy
The economy is reliant on the 'fortunes of the well-to-do' says Moody's—if the ultra-rich get nervy that means recession
By
Eleanor Pringle